MedTrace Logo

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

NCT06064591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 458

Last updated 2026-03-11

No results posted yet for this study

Summary

Understanding the sexual conversion of the malaria parasite is essential to interrupt malaria transmission. A new tool is developed that, based on expression analysis of sexual stage biomarkers, will estimate sexual conversion rates in natural infections.

Conditions

  • Severe Malaria
  • Uncomplicated Malaria
  • Asyptomatic Plasmodium Infection

Sponsors & Collaborators

  • Instituto Nacional de Saúde, Mozambique

    collaborator OTHER_GOV

  • Clinical Research Unit of Nanoro (CRUN), Burkina Faso

    collaborator UNKNOWN

  • Barcelona Institute for Global Health

    collaborator OTHER

  • Leiden University Medical Center

    collaborator OTHER

  • KU Leuven

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Anna Rosanas-Urgell, Prof · ITM

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2025-12-09
Completion
2025-12-09

Countries

  • Belgium
  • Burkina Faso
  • Mozambique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06064591 on ClinicalTrials.gov